AAAAAA

   
Results: 1-13 |
Results: 13
PERIPHERAL-NERVE STIMULATION AND CLINICAL-ASSESSMENT FOR DOSING OF NEUROMUSCULAR BLOCKING-AGENTS IN CRITICALLY ILL PATIENTS - REPLY
Authors: RUDIS MI ANGUS E ZAROWITZ BJ
Citation: Mi. Rudis et al., PERIPHERAL-NERVE STIMULATION AND CLINICAL-ASSESSMENT FOR DOSING OF NEUROMUSCULAR BLOCKING-AGENTS IN CRITICALLY ILL PATIENTS - REPLY, Critical care medicine, 26(4), 1998, pp. 805-805
RETROSPECTIVE PHARMACOECONOMIC EVALUATION OF DOSING VECURONIUM BY PERIPHERAL-NERVE STIMULATION VERSUS STANDARD CLINICAL-ASSESSMENT IN CRITICALLY-ILL PATIENTS
Authors: ZAROWITZ BJ RUDIS MI LAI K PETITTA A LULEK M
Citation: Bj. Zarowitz et al., RETROSPECTIVE PHARMACOECONOMIC EVALUATION OF DOSING VECURONIUM BY PERIPHERAL-NERVE STIMULATION VERSUS STANDARD CLINICAL-ASSESSMENT IN CRITICALLY-ILL PATIENTS, Pharmacotherapy, 17(2), 1997, pp. 327-332
A PROSPECTIVE, RANDOMIZED, CONTROLLED EVALUATION OF PERIPHERAL-NERVE STIMULATION VERSUS STANDARD CLINICAL DOSING OF NEUROMUSCULAR BLOCKING-AGENTS IN CRITICALLY ILL PATIENTS
Authors: RUDIS MI SIKORA CA ANGUS E PETERSON E POPOVICH J HYZY R ZAROWITZ BJ
Citation: Mi. Rudis et al., A PROSPECTIVE, RANDOMIZED, CONTROLLED EVALUATION OF PERIPHERAL-NERVE STIMULATION VERSUS STANDARD CLINICAL DOSING OF NEUROMUSCULAR BLOCKING-AGENTS IN CRITICALLY ILL PATIENTS, Critical care medicine, 25(4), 1997, pp. 575-583
POPULATION PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF VECURONIUM(V) IN CRITICALLY ILL PATIENTS
Authors: RUDIS MI AUCLAIR B ZAROWITZ BJ DUCHARME MP
Citation: Mi. Rudis et al., POPULATION PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF VECURONIUM(V) IN CRITICALLY ILL PATIENTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 65-65
LOW-DOSE DOPAMINE IN ACUTE OLIGURIC RENAL-FAILURE
Authors: RUDIS MI ZAROWITZ BJ
Citation: Mi. Rudis et Bj. Zarowitz, LOW-DOSE DOPAMINE IN ACUTE OLIGURIC RENAL-FAILURE, The American journal of medicine, 102(3), 1997, pp. 320-321
TECHNICAL AND INTERPRETIVE PROBLEMS OF PERIPHERAL-NERVE STIMULATION IN MONITORING NEUROMUSCULAR BLOCKADE IN THE INTENSIVE-CARE UNIT
Authors: RUDIS MI GUSLITS BG ZAROWITZ BJ
Citation: Mi. Rudis et al., TECHNICAL AND INTERPRETIVE PROBLEMS OF PERIPHERAL-NERVE STIMULATION IN MONITORING NEUROMUSCULAR BLOCKADE IN THE INTENSIVE-CARE UNIT, The Annals of pharmacotherapy, 30(2), 1996, pp. 165-172
BAR CODE DOCUMENTATION OF PHARMACOTHERAPY SERVICES IN INTENSIVE-CARE UNITS
Authors: ZAROWITZ BJ PETITTA A RUDIS MI HORST HM HYZY R
Citation: Bj. Zarowitz et al., BAR CODE DOCUMENTATION OF PHARMACOTHERAPY SERVICES IN INTENSIVE-CARE UNITS, Pharmacotherapy, 16(2), 1996, pp. 261-266
DISPOSITION OF PROCAINAMIDE IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE RECEIVING MEDICAL THERAPY
Authors: TISDALE JE RUDIS MI PADHI ID BORZAK S SVENSSON CK WEBB CR ACCIAIOLI J WARE JA KREPOSTMAN A ZAROWITZ BJ
Citation: Je. Tisdale et al., DISPOSITION OF PROCAINAMIDE IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE RECEIVING MEDICAL THERAPY, Journal of clinical pharmacology, 36(1), 1996, pp. 35-41
IS IT TIME TO REPOSITION VASOPRESSORS AND INOTROPES IN SEPSIS
Authors: RUDIS MI BASHA MA ZAROWITZ BJ
Citation: Mi. Rudis et al., IS IT TIME TO REPOSITION VASOPRESSORS AND INOTROPES IN SEPSIS, Critical care medicine, 24(3), 1996, pp. 525-537
ECONOMIC-IMPACT OF PROLONGED MOTOR WEAKNESS COMPLICATING NEUROMUSCULAR BLOCKADE IN THE INTENSIVE-CARE UNIT
Authors: RUDIS MI GUSLITS BJ PETERSON EL HATHAWAY SJ ANGUS E BEIS S ZAROWITZ BJ
Citation: Mi. Rudis et al., ECONOMIC-IMPACT OF PROLONGED MOTOR WEAKNESS COMPLICATING NEUROMUSCULAR BLOCKADE IN THE INTENSIVE-CARE UNIT, Critical care medicine, 24(10), 1996, pp. 1749-1756
INHIBITION OF N-ACETYLATION OF PROCAINAMIDE AND RENAL CLEARANCE OF N-ACETYLPROCAINAMIDE BY PARA-AMINOBENZOIC ACID IN HUMANS
Authors: TISDALE JE RUDIS MI PADHI ID SVENSSON CK WEBB CR BORZAK S WARE JA KREPOSTMAN A ZAROWITZ BJ
Citation: Je. Tisdale et al., INHIBITION OF N-ACETYLATION OF PROCAINAMIDE AND RENAL CLEARANCE OF N-ACETYLPROCAINAMIDE BY PARA-AMINOBENZOIC ACID IN HUMANS, Journal of clinical pharmacology, 35(9), 1995, pp. 902-910
PROCAINAMIDE (PA) PHARMACOKINETICS IN CONGESTIVE-HEART-FAILURE (CHF)
Authors: TISDALE JE RUDIS MI PADHI ID BORZAK S SVENSSON CK WEBB CR WARE JA KREPOSTMAN A ZAROWITZ BJ
Citation: Je. Tisdale et al., PROCAINAMIDE (PA) PHARMACOKINETICS IN CONGESTIVE-HEART-FAILURE (CHF), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 142-142
INHIBITION OF PROCAINAMIDE (PA) N-ACETYLATION BY PARA-AMINOBENZOIC ACID (PABA)
Authors: TISDALE JE RUDIS MI PADHI ID SVENSSON CK WEBB CR BORZAK S WARE JA KREPOSTMAN A ZAROWITZ BJ
Citation: Je. Tisdale et al., INHIBITION OF PROCAINAMIDE (PA) N-ACETYLATION BY PARA-AMINOBENZOIC ACID (PABA), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 184-184
Risultati: 1-13 |